GlassScriptPhysician profile
George R Pronesti
NPI 1275649923
$3,962.54
in general payments reported to CMS, 2019-2025
16 companies · $475 in 2025
The $475 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $333 · 2020: $165 · 2021: $501 · 2022: $316 · 2023: $349 · 2024: $1,823 · 2025: $475.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,500 · Food and Beverage: $1,147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,500.00 |
| Food and Beverage | $1,146.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $1,801.82 | 2021-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Light Adjustable Lens (Lal) |
| Alcon Vision LLC | $846.75 | 2020-2025 | Clareon, Wavelight Refractive Suite, Tryptyr |
| Glaukos Corporation | $483.69 | 2019-2023 | Istent Infinite Trabecular Micro-Bypass System Model Is3 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $234.64 | 2019-2021 | |
| Amgen INC. | $134.14 | 2024-2025 | Tepezza |
| Biohaven Pharmaceuticals, INC. | $104.20 | 2021 | |
| Abbvie INC. | $88.59 | 2022-2025 | |
| Ani Pharmaceuticals, INC. | $44.08 | 2025 | Purified Cortrophin Gel |
| Merz Pharmaceuticals, LLC | $39.70 | 2025 | Xeomin |
| Omeros Corporation | $38.93 | 2019 | |
| Carl Zeiss Meditec, INC. | $34.48 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $30.09 | 2022 | |
| Ivantis, INC | $29.09 | 2020 | |
| Sun Pharmaceutical Industries INC. | $22.29 | 2020 | |
| Allergan, INC. | $16.03 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $14.02 | 2025 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Pronesti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.